Johnson JA - Search Results

1

Prospective study of hyperglycemia and cancer risk: response to Stattin et al.

Bowker SL, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2007 Jul;30(7):e77; author reply e78. doi: 10.2337/dc07-0544. Diabetes Care. 2007. PMID: 17596500 No abstract available.

2

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2006 Feb;29(2):254-8. doi: 10.2337/diacare.29.02.06.dc05-1558. Diabetes Care. 2006. PMID: 16443869

3

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2006 Aug;29(8):1990-1. doi: 10.2337/dc06-0997. Diabetes Care. 2006. PMID: 16873829 No abstract available.

4

Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women.

Bowker SL, Richardson K, Marra CA, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Diabetes Care. 2011 Dec;34(12):2542-4. doi: 10.2337/dc11-1199. Epub 2011 Oct 4. Diabetes Care. 2011. PMID: 21972408 Free PMC article.

5

Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study.

Colmers IN, Majumdar SR, Yasui Y, Bowker SL, Marra CA, Johnson JA. Colmers IN, et al. Among authors: johnson ja. Diabetes Care. 2013 Oct;36(10):3070-5. doi: 10.2337/dc13-0045. Epub 2013 Aug 29. Diabetes Care. 2013. PMID: 23990517 Free PMC article.

6

Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.

Zanders MM, Renehan AG, Bowker SL, Carstensen B, van de Poll-Franse LV, Johnson JA. Zanders MM, et al. Among authors: johnson ja. Diabetes Care. 2014 Oct;37(10):e221-2. doi: 10.2337/dc14-1380. Diabetes Care. 2014. PMID: 25249682 No abstract available.

7

Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.

Bowker SL, Lin M, Eurich DT, Johnson JA. Bowker SL, et al. Among authors: johnson ja. Can J Diabetes. 2017 Apr;41(2):204-210. doi: 10.1016/j.jcjd.2016.08.227. Epub 2016 Nov 29. Can J Diabetes. 2017. PMID: 27908558

8

Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis.

Colmers IN, Bowker SL, Johnson JA. Colmers IN, et al. Among authors: johnson ja. Diabetes Metab. 2012 Dec;38(6):475-84. doi: 10.1016/j.diabet.2012.06.003. Epub 2012 Oct 5. Diabetes Metab. 2012. PMID: 23041441 Review.

9

Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.

Colmers IN, Bowker SL, Tjosvold LA, Johnson JA. Colmers IN, et al. Among authors: johnson ja. Diabetes Metab. 2012 Dec;38(6):485-506. doi: 10.1016/j.diabet.2012.08.011. Epub 2012 Nov 15. Diabetes Metab. 2012. PMID: 23159131 Review.

10

Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis.

Colmers IN, Bowker SL, Majumdar SR, Johnson JA. Colmers IN, et al. Among authors: johnson ja. CMAJ. 2012 Sep 4;184(12):E675-83. doi: 10.1503/cmaj.112102. Epub 2012 Jul 3. CMAJ. 2012. PMID: 22761478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,773 results

Search Page

Filters